Patient-reported Outcomes in the Bergen Early Cardiac Rehabilitation Study
NCT ID: NCT03810599
Last Updated: 2019-01-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
870 participants
INTERVENTIONAL
2013-09-09
2029-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Electronic Cardiac Rehabilitation (eCardiacRehab) Feasibility Study
NCT06759805
A Prospective Cohort Study of Heart Patients Included in Exercise Based Rehabilitation in Oslo
NCT02249260
Exercise Training Adherence After Cardiac Rehabilitation in Coronary Heart Disease Patients
NCT01246570
Effect of Standard Care Rehabilitation Versus Interval Treadmill Training After Myocardial Infarction
NCT00235339
Exercise as a Life-long Medicine in Patients With Coronary Artery Disease
NCT02228603
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Early cardiac rehabilitation
Single Group: 5 week cardiac rehabilitation programme. Pre-post comparison.
Early cardiac rehabilitation
This is an early cardiac rehabilitation programme starting 1-2 weeks after hospital discharge (Phase 2A rehabilitation). The programme provided by a multidisciplinary team includes individual counseling, educational sessions and discussion in groups, and exercise training sessions three days a week for five weeks.
For additional analysis there will be a comparison group that did not receive the intervention for practical reasons.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Early cardiac rehabilitation
This is an early cardiac rehabilitation programme starting 1-2 weeks after hospital discharge (Phase 2A rehabilitation). The programme provided by a multidisciplinary team includes individual counseling, educational sessions and discussion in groups, and exercise training sessions three days a week for five weeks.
For additional analysis there will be a comparison group that did not receive the intervention for practical reasons.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* \>=18 years of age
* Has performed a negative exercise test (bike or treadmill) and thereby able to participate in exercise training.
Exclusion Criteria
* Unstable angina pectoris
* Aortic stenosis
* Left ventricular ejection fraction \<30%
* Heart failure NYHA class III-IV
* Serious arrhythmia in need of treatment
* Being on the waiting list for percutaneous coronary intervention or coronary artery bypass grafting.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Haukeland University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Tone M Norekvål, PhD
Role: PRINCIPAL_INVESTIGATOR
Haukeland University Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Haukeland University Hospital
Bergen, , Norway
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Related Links
Access external resources that provide additional context or updates about the study.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2014/333
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.